More about

Cardioversion

News
May 22, 2024
3 min read
Save

Pulsed field ablation for AF may reduce arrhythmia burden better than thermal ablation

Pulsed field ablation lowered the odds of high residual atrial arrhythmia burden compared with thermal ablation for patients with atrial fibrillation at 1 year, according to a subanalysis of the ADVENT trial presented at Heart Rhythm 2024.

News
December 23, 2023
2 min read
Save

Catheter ablation linked to fewer rehospitalizations in patients with AF plus HFpEF

Catheter ablation for atrial fibrillation was associated with lower incidence of hospitalization for worsening HF vs. drug therapy in patients with HF with preserved ejection fraction, researchers reported.

News
December 17, 2023
2 min read
Save

SK ion channel inhibitor shows ability to convert atrial fibrillation to sinus rhythm

In a proof-of-concept phase 2 trial, a novel SK ion channel inhibitor successfully converted atrial fibrillation to sinus rhythm compared with placebo.

News
November 28, 2023
3 min read
Save

Adhesive-based wearable cardioverter defibrillator beats performance goals

PHILADELPHIA — A novel adhesive-based wearable cardioverter defibrillator was associated with high rates of patient compliance and low rates of adverse events, researchers reported at the American Heart Association Scientific Sessions.

News
January 31, 2022
2 min read
Save

After AF ablation, dronedarone may be safer, more effective than sotalol

After atrial fibrillation ablation, dronedarone was associated with lower risk for recurrent hospitalizations and repeat AF ablations compared with sotalol, researchers reported.

News
March 19, 2020
1 min read
Save

RAFF-2

Pharmacological cardioversion followed by electrical cardioversion vs. electrical cardioversion alone in patients with acute atrial fibrillation.

News
January 31, 2020
2 min read
Save

Electrical cardioversion alone or with procainamide confers similar outcomes for AF

Sinus rhythm was restored in an effective, safe and rapid manner using drug-shock or shock-only strategies among patients in the ED with acute atrial fibrillation, according to results of the RAFF-2 trial published in The Lancet.

News
December 10, 2019
6 min read
Save

FDA panel does not recommend approval of vernakalant for AF

Citing safety concerns, the Cardiovascular and Renal Drug Advisory Committee of the FDA voted 2-11 against approval of vernakalant for the rapid conversion of recent-onset atrial fibrillation.

News
October 10, 2019
2 min read
Save

ATTEST: Radiofrequency ablation superior to antiarrhythmic drugs for AF progression

PARIS — Early radiofrequency ablation was superior to antiarrhythmic drugs to delay the progression to persistent atrial fibrillation among patients with drug-refractory paroxysmal AF, according to 3-year data from the ATTEST trial presented at the European Society of Cardiology Congress.

News
August 31, 2019
3 min read
Save

Cardioversion with maximum-fixed shocks confers better outcomes vs. low-escalating energy shocks

PARIS — Cardioversion with maximum-fixed energy shocks was more effective than low-escalating energy shocks for the treatment of patients with atrial fibrillation, according to a late-breaking science presentation at the European Society of Cardiology Congress.

View more